High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation

Metabolic Syndrome and Related Disorders - United States
doi 10.1089/met.2019.0115
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention

Lipids
Organic ChemistryBiochemistryCell Biology
2010English

Metabolic Syndrome, Inflammation and Atherosclerosis

Vascular Health and Risk Management
PharmacologyCardiologyEndocrinologyPublic HealthHematologyEnvironmentalCardiovascular MedicineMedicineOccupational HealthMetabolismDiabetes
2006English

Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor

Medicinski Arhiv
Medicine
2015English

Adiposity Significantly Modifies Genetic Risk for Dyslipidemia

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
2014English

Corrigendum to “APOA5 Variants Predispose Hyperlipidemic Patients to Atherogenic Dyslipidemia and Subclinical Atherosclerosis” [Atherosclerosis 240/1 (2015) 98–104]

Atherosclerosis
Cardiovascular MedicineCardiology
2016English

Atherogenic Dyslipidemia in Diabetic Nephropathy: Lipoprotein (A), Lipid Ratios and Atherogenic Index

International Journal of Research in Medical Sciences
2013English

Dyslipidemia-Associated Alterations in B Cell Subpopulation Frequency and Phenotype During Experimental Atherosclerosis

Atherosclerosis
Cardiovascular MedicineCardiology
2016English

Chronic Kidney Disease, Dyslipidemia, and Atherosclerosis

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2012English

The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline

JAMA - Journal of the American Medical Association
Medicine
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy